CSL Behring Germany today announced that the first haemophilia B patient in Germany was treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at the Hemophilia Treatment Center at ...

When the first reports of a new COVID-19 variant emerge, scientists worldwide scramble to answer a critical question: Will ...